2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5096 | 2013 |
Rituximab versus cyclophosphamide for ANCA-associated vasculitis JH Stone, PA Merkel, R Spiera, P Seo, CA Langford, GS Hoffman, ... New England Journal of Medicine 363 (3), 221-232, 2010 | 3039 | 2010 |
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I CG Helmick, DT Felson, RC Lawrence, S Gabriel, R Hirsch, CK Kwoh, ... Arthritis & Rheumatism 58 (1), 15-25, 2008 | 2932 | 2008 |
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the rheumatic diseases 75 (9), 1583-1594, 2016 | 1346 | 2016 |
EULAR recommendations for the management of primary small and medium vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 310-317, 2009 | 1278 | 2009 |
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist JH Korn, M Mayes, M Matucci Cerinic, M Rainisio, J Pope, E Hachulla, ... Arthritis & Rheumatism 50 (12), 3985-3993, 2004 | 913 | 2004 |
EULAR recommendations for the management of large vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 318-323, 2009 | 843 | 2009 |
Efficacy of remission-induction regimens for ANCA-associated vasculitis U Specks, PA Merkel, P Seo, R Spiera, CA Langford, GS Hoffman, ... New England Journal of Medicine 369 (5), 417-427, 2013 | 829 | 2013 |
Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ... New England Journal of Medicine 376 (20), 1921-1932, 2017 | 827 | 2017 |
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis B Hellmich, O Flossmann, WL Gross, P Bacon, JW Cohen-Tervaert, ... Annals of the rheumatic diseases 66 (5), 605-617, 2007 | 708 | 2007 |
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ... Wiley Periodicals, Inc., 2013 | 684 | 2013 |
Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta‐analysis AD Mahr, JA Jover, RF Spiera, C Hernández‐García, ... Arthritis & rheumatism 56 (8), 2789-2797, 2007 | 682 | 2007 |
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis GS Hoffman, MC Cid, DB Hellmann, L Guillevin, JH Stone, J Schousboe, ... Arthritis & Rheumatism 46 (5), 1309-1318, 2002 | 680 | 2002 |
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial GS Hoffman, MC Cid, KE Rendt-Zagar, PA Merkel, CM Weyand, JH Stone, ... Annals of internal medicine 146 (9), 621-630, 2007 | 653 | 2007 |
Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis M Walsh, PA Merkel, CA Peh, WM Szpirt, X Puéchal, S Fujimoto, ... New England Journal of Medicine 382 (7), 622-631, 2020 | 620 | 2020 |
Avacopan for the treatment of ANCA-associated vasculitis DRW Jayne, PA Merkel, TJ Schall, P Bekker New England Journal of Medicine 384 (7), 599-609, 2021 | 606 | 2021 |
ANCA-associated vasculitis AR Kitching, HJ Anders, N Basu, E Brouwer, J Gordon, DR Jayne, ... Nature reviews Disease primers 6 (1), 71, 2020 | 598 | 2020 |
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial M Matucci-Cerinic, CP Denton, DE Furst, MD Mayes, VM Hsu, ... Annals of the rheumatic diseases 70 (1), 32-38, 2011 | 582 | 2011 |
Guide to bone health and disease in cystic fibrosis RM Aris, PA Merkel, LK Bachrach, DS Borowitz, MP Boyle, SL Elkin, ... The Journal of Clinical Endocrinology & Metabolism 90 (3), 1888-1896, 2005 | 561 | 2005 |
A disease‐specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score JH Stone, GS Hoffman, PA Merkel, YI Min, ML Uhlfelder, DB Hellmann, ... Arthritis & Rheumatism 44 (4), 912-920, 2001 | 545 | 2001 |